Switch to:
GuruFocus has detected 4 Warning Signs with Progenics Pharmaceuticals Inc $PGNX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Progenics Pharmaceuticals Inc (NAS:PGNX)
Cash Flow from Others
$-2.29 Mil (TTM As of Dec. 2016)

Progenics Pharmaceuticals Inc's cash flow from others for the three months ended in Dec. 2016 was $-3.39 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2016 was $-2.29 Mil.


Definition

Progenics Pharmaceuticals Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2016 was 0.084 (Mar. 2016 ) + 0.429 (Jun. 2016 ) + 0.594 (Sep. 2016 ) + -3.392 (Dec. 2016 ) = $-2.29 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Progenics Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others -0.450.970.98-0.010.00-0.330.923.991.60-4.10

Progenics Pharmaceuticals Inc Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Cash Flow from Others 0.801.450.300.79-0.180.570.080.430.59-3.39
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK